BioMarin announces positive Phase 3 VOXZOGO results in NEJM
BioMarin said its Phase 3 VOXZOGO (vosoritide) study in hypochondroplasia has positive results, published as NEJM evidence.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.